Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5278629
Max Phase: Preclinical
Molecular Formula: C27H20ClN5OS
Molecular Weight: 498.01
Associated Items:
ID: ALA5278629
Max Phase: Preclinical
Molecular Formula: C27H20ClN5OS
Molecular Weight: 498.01
Associated Items:
Canonical SMILES: O=C1CS/C(=N\c2cc(-c3cn(Cc4ccccc4)c4ccccc34)nn2-c2cccc(Cl)c2)N1
Standard InChI: InChI=1S/C27H20ClN5OS/c28-19-9-6-10-20(13-19)33-25(29-27-30-26(34)17-35-27)14-23(31-33)22-16-32(15-18-7-2-1-3-8-18)24-12-5-4-11-21(22)24/h1-14,16H,15,17H2,(H,29,30,34)
Standard InChI Key: RYFAGLFXRLWQSM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 498.01 | Molecular Weight (Monoisotopic): 497.1077 | AlogP: 6.05 | #Rotatable Bonds: 5 |
Polar Surface Area: 64.21 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 7.57 | CX Basic pKa: 0.72 | CX LogP: 6.64 | CX LogD: 6.42 |
Aromatic Rings: 5 | Heavy Atoms: 35 | QED Weighted: 0.32 | Np Likeness Score: -1.53 |
1. Soni JP, Chilvery S, Sharma A, Reddy GN, Godugu C, Shankaraiah N.. (2023) Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors., 14 (3): [PMID:36970141] [10.1039/d2md00442a] |
Source(1):